Carotid Endothelial VCAM-1 Is an Early Marker of Carotid Atherosclerosis and Predicts Coronary Artery Disease in Swine

DOI: 10.4236/jbise.2015.811073   PDF   HTML   XML   5,774 Downloads   6,161 Views   Citations


Objective: The aim was to determine if endothelial VCAM-1 (eVCAM-1) expression in the common carotid artery (CCA) would correlate with predictive markers of atherosclerotic disease, would precede reduction of markers of endothelial cell function and would predict coronary artery disease (CAD). Methods and results: Carotid arterial segments (bifurcation, proximal and distal CCA) were harvested from 14 and 24 month-old male castrated familial hypercholesterolemic (FH) swine, a model of spontaneous atherosclerosis. Quantification of local expression of eVCAM-1, intimal macrophage accumulation, oxidative stress, intima-media (I/M) ratio, intima-media thickness (IMT), endothelial nitric oxide synthase (eNOS) and phosphorylated eNOS (p-eNOS) in selected regions of the carotids revealed a relationship between local inflammation and atherosclerotic plaque progression. Importantly, inflammation was not uniform throughout the CCA. Endothelial VCAM-1 expression was the greatest at the bifurcation and increased with age. Finally, eVCAM-1 best estimated the severity of CAD compared to blood levels of glucose, hypercholesterolemia, carotid IMT, and p-eNOS. Conclusion: Our data suggested that eVCAM-1 was closely associated with atherosclerotic plaque progression and preceded impairment of EDD. Thus, this study supported the use of carotid VCAM-1 targeting agents to estimate the severity of CAD.

Share and Cite:

Masseau, I. and Bowles, D. (2015) Carotid Endothelial VCAM-1 Is an Early Marker of Carotid Atherosclerosis and Predicts Coronary Artery Disease in Swine. Journal of Biomedical Science and Engineering, 8, 767-779. doi: 10.4236/jbise.2015.811073.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Gimbrone Jr., M.A., Topper, J.N., Nagel, T., Anderson, K.R. and Garcia-Cardena, G. (2000) Endothelial Dysfunction, Hemodynamic Forces, and Atherogenesis. Annals of the New York Academy of Sciences, 902, 230-239.
[2] de Groot, E., van Leuven, S.I., Duivenvoorden, R., Meuwese, M.C., Akdim, F., Bots, M.L. and Kastelein, J.J. (2008) Measurement of Carotid Intima-Media Thickness to Assess Progression and Regression of Atherosclerosis. Nature Clinical Practice Cardiovascular Medicine, 5, 280-288.
[3] Rossi, R., Nuzzo, A., Origliani, G. and Modena, M.G. (2008) Prognostic Role of Flow-Mediated Dilation and Cardiac Risk Factors in Post-Menopausal Women. Journal of the American College of Cardiology, 51, 997-1002.
[4] Karatzis, E.N., Ikonomidis, I., Vamvakou, G.D., Papaioannou, T.G., Protogerou, A.D., Andreadou, I., Voidonikola, P.T., Karatzi, K.N., Papamichael, C.M. and Lekakis, J.P. (2006) Long-Term Prognostic Role of Flow-Mediated Dilatation of the Brachial Artery after Acute Coronary Syndromes without ST Elevation. American Journal of Cardiology, 98, 1424-1428.
[5] Jambrik, Z., Venneri, L., Varga, A., Rigo, F., Borges, A. and Picano, E. (2004) Peripheral Vascular Endothelial Function Testing for the Diagnosis of Coronary Artery Disease. American Heart Journal, 148, 684-689.
[6] Schroeder, S., Enderle, M.D., Ossen, R., Meisner, C., Baumbach, A., Pfohl, M., Herdeg, C., Oberhoff, M., Haering, H.U. and Karsch, K.R. (1999) Noninvasive De-termination of Endothelium-Mediated Vasodilation as a Screening Test for Coronary Artery Disease: Pilot Study to Assess the Predictive Value in Comparison with Angina Pectoris, Exercise Electrocardiography, and Myocardial Perfusion Imaging. American Heart Journal, 138, 731-739.
[7] Reddy, K.G., Nair, R.N., Sheehan, H.M. and Hodgson, J.M. (1994) Evidence That Selective Endothelial Dysfunction May Occur in the Absence of Angiographic or Ultrasound Atherosclerosis in Patients with Risk Factors for Atherosclerosis. Journal of the American College of Cardiology, 23, 833-843.
[8] Rueda-Clausen, C.F., Lopez-Jaramillo, P., Luengas, C., del Pilar Oubina, M., Cachofeiro, V. and Lahera, V. (2009) Inflammation But Not Endothelial Dysfunction Is Associated with the Severity of Coronary Artery Disease in Dyslipidemic Subjects. Mediators of Inflammation, 2009, Article ID: 469169.
[10] Turk, J.R., Henderson, K.K., Vanvickle, G.D., Watkins, J. and Laughlin, M.H. (2005) Arterial Endothelial Function in a Porcine Model of Early Stage Atherosclerotic Vascular Disease. International Journal of Experimental Pathology, 86, 335-345.
[11] Prescott, M.F., McBride, C.H., Hasler-Rapacz, J., Von Linden, J. and Rapacz, J. (1991) Development of Complex Atherosclerotic Lesions in Pigs with Inherited Hyper-LDL Cholesterolemia Bearing Mutant Alleles for Apolipoprotein B. American Journal of Pathology, 139, 139-147.
[12] Malek, A.M., Alper, S.L. and Izumo, S. (1999) Hemodynamic Shear Stress and Its Role in Atherosclerosis. JAMA, 282, 2035-2042.
[13] Hasler-Rapacz, J., Prescott, M.F., Von Linden-Reed, J., Rapacz Jr., J.M., Hu, Z. and Rapacz, J. (1995) Elevated Concentrations of Plasma Lipids and Apolipoproteins B, C-III, and E Are Associated with the Progression of Coronary Artery Disease in Familial Hypercholesterolemic Swine. Arteriosclerosis, Thrombosis, and Vascular Biology, 15, 583- 592.
[14] Hambrecht, R., Adams, V., Erbs, S., Linke, A., Krankel, N., Shu, Y., Baither, Y., Gielen, S., Thiele, H., Gummert, J.F., Mohr, F.W. and Schuler, G. (2003) Regular Physical Activity Improves Endothelial Function in Patients with Coronary Artery Disease by Increasing Phosphorylation of Endothelial Nitric Oxide Synthase. Circulation, 107, 3152-3158.
[15] Kaufmann, B.A., Carr, C.L., Belcik, J.T., Xie, A., Yue, Q., Chadderdon, S., Caplan, E.S., Khangura, J., Bullens, S., Bunting, S. and Lindner, J.R. (2010) Molecular Imaging of the Initial Inflammatory Response in Atherosclerosis: Implications for Early Detection of Disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 30, 54-59.
[16] Dai, G., Kaazempur-Mofrad, M.R., Natarajan, S., Zhang, Y., Vaughn, S., Blackman, B.R., Kamm, R.D., Garcia-Cardena, G. and Gim-brone Jr., M.A. (2004) Distinct Endothelial Phenotypes Evoked by Arterial Waveforms Derived from Atherosclerosis-Susceptible and -Resistant Regions of Human Vasculature. Proceedings of the National Academy of Sciences of the United States of America, 101, 14871-14876.
[17] Irace, C., Carallo, C., Crescenzo, A., Motti, C., De Franceschi, M.S., Mattioli, P.L. and Gnasso, A. (1999) NIDDM Is associated with Lower Wall Shear Stress of the Common Carotid Artery. Diabetes, 48, 193-197.
[18] Spiecker, M., Peng, H.B. and Liao, J.K. (1997) Inhibition of Endothelial Vascular Cell Adhesion Molecule-1 Expression by Nitric Oxide Involves the Induction and Nuclear Translocation of Ikappa Balpha. Journal of Biological Chemistry, 272, 30969-30974.
[19] Li, H., Cybulsky, M.I., Gimbrone Jr., M.A. and Libby, P. (1993) An Atherogenic Diet Rapidly Induces VCAM-1, a Cytokine-Regulatable Mononuclear Leukocyte Adhesion Molecule, in Rabbit Aortic Endothelium. Arteriosclerosis, Thrombosis, and Vascular Biology, 13, 197-204.
[20] Tao, L., Liu, H.R., Gao, E., Teng, Z.P., Lopez, B.L., Christopher, T.A., Ma, X.L., Batinic-Haberle, I., Willette, R.N., Ohlstein, E.H. and Yue, T.L. (2003) Antioxidative, Antinitrative, and Vasculoprotective Effects of a Peroxisome Proliferator-Activated Receptor-γ Agonist in Hypercholesterolemia. Circulation, 108, 2805-2811.
[21] Zou, M.H., Shi, C. and Cohen, R.A. (2002) High Glucose via Peroxynitrite Causes Tyrosine Nitration and Inactivation of Prostacyclin Synthase That Is Associated with Thromboxane/Prostaglandin H2 Receptor-Mediated Apoptosis and Adhesion Molecule Expression in Cultured Human Aortic Endothelial Cells. Diabetes, 51, 198-203.
[22] Ku, D.N., Giddens, D.P., Zarins, C.K. and Glagov, S. (1985) Pulsatile Flow and Atherosclerosis in the Human Carotid Bifurcation. Positive Correlation between Plaque Location and Low Oscillating Shear Stress. Arteriosclerosis, 5, 293- 302.
[23] Endres, M., Laufs, U., Merz, H. and Kaps, M. (1997) Focal Expression of Intercellular Adhesion Molecule-1 in the Human Carotid Bifurcation. Stroke, 28, 77-82.
[24] Aronson, D. and Rayfield, E.J. (2002) How Hyperglycemia Promotes Atherosclerosis: Molecular Mechanisms. Cardiovascular Diabetology, 1, 1.
[25] Barth, J.D. and Arntzenius, A.C. (1991) Progression and Regression of Atherosclerosis, What Roles for LDL-Cholesterol and HDL-Cholesterol: A Perspective. European Heart Journal, 12, 952-957.
[26] Kowala, M.C., Recce, R., Beyer, S., Gu, C. and Valentine, M. (2000) Characterization of Atherosclerosis in LDL Receptor Knockout Mice: Macrophage Accumulation Correlates with Rapid and Sustained Expression of Aortic MCP-1/JE. Atherosclerosis, 149, 323-330.
[27] Altannavch, T.S., Roubalova, K., Kucera, P. and Andel, M. (2004) Effect of High Glucose Concentrations on Expression of ELAM-1, VCAM-1 and ICAM-1 in HUVEC with and without Cytokine Activation. Physiological Research, 53, 77-82.
[28] Esposito, C., Fasoli, G., Plati, A.R., Bellotti, N., Conte, M.M., Cornacchia, F., Foschi, A., Mazzullo, T., Semeraro, L. and Dal Canton, A. (2001) Long-Term Exposure to High Glucose Up-Regulates VCAM-Induced Endothelial Cell Adhesiveness to PBMC. Kidney International, 59, 1842-1849.
[29] Kowalska, I., Straczkowski, M., Szelachowska, M., Kinalska, I., Prokop, J., Bachorzewska-Gajewska, H. and Stepien, A. (2002) Circulating E-Selectin, Vascular Cell Adhesion Molecule-1, and Intercellular Adhesion Molecule-1 in Men with Coronary Artery Disease Assessed by Angiography and Disturbances of Carbohydrate Metabolism. Metabolism, 51, 733-736.
[30] Kannel, W.B. and McGee, D.L. (1979) Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study. Diabetes Care, 2, 120-126.
[31] Nakashima, Y., Raines, E.W., Plump, A.S., Breslow, J.L. and Ross, R. (1998) Upregulation of VCAM-1 and ICAM-1 at Atherosclerosis-Prone Sites on the Endothelium in the ApoE-Deficient Mouse. Arteriosclerosis, Thrombosis, and Vascular Biology, 18, 842-851.
[32] Brownlee, M., Cerami, A. and Vlassara, H. (1988) Advanced Glyco-sylation End Products in Tissue and the Biochemical Basis of Diabetic Complications. New England Journal of Medicine, 318, 1315-1321.
[33] Wautier, J.L., Wautier, M.P., Schmidt, A.M., Anderson, G.M., Hori, O., Zoukourian, C., Capron, L., Chappey, O., Yan, S.D., Brett, J., et al. (1994) Advanced Glycation End Products (AGEs) on the Surface of Diabetic Erythrocytes Bind to the Vessel Wall via a Specific Receptor Inducing Oxidant Stress in the Vasculature: A Link between Surface-Associated AGEs and Diabetic Complications. Proceedings of the National Academy of Sciences of the United States of America, 91, 7742-7746.
[34] Yan, S.D., Schmidt, A.M., Anderson, G.M., Zhang, J., Brett, J., Zou, Y.S., Pinsky, D. and Stern, D. (1994) Enhanced Cellular Oxidant Stress by the Interaction of Advanced Glycation End Products with Their Receptors/Binding Proteins. Journal of Biological Chemistry, 269, 9889-9897.
[35] Schmidt, A.M., Hori, O., Chen, J.X., Li, J.F., Crandall, J., Zhang, J., Cao, R., Yan, S.D., Brett, J. and Stern, D. (1995) Advanced Glycation End Products Interacting with Their Endothelial Receptor Induce Expression of Vascular Cell Adhesion Molecule-1 (VCAM-1) in Cultured Human Endothelial Cells and in Mice. A Potential Mechanism for the Accelerated Vasculopathy of Diabetes. Journal of Clinical Investigation, 96, 1395-1403.
[36] Rogers, I.S., Nasir, K., Figueroa, A.L., Cury, R.C., Hoffmann, U., Vermylen, D.A., Brady, T.J. and Tawakol, A. (2010) Feasibility of FDG Imaging of the Coronary Arteries: Comparison between Acute Coronary Syndrome and Stable Angina. JACC: Cardiovascular Imaging, 3, 388-397.

comments powered by Disqus

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.